The basic data analysis is similar to that of a typical cohort study, and the results can be summarized in a contingency table. All analyses herein presented are a comparison of the experience of such preselected groups regardless of their actual status with respect to receiving the vaccine. St. Louis: Mosby, 1996; New York: Springer-Verlag, 1998. In 1941, in his report of a controlled trial of a whooping cough vaccine, Joseph Bell wrote as follows: Obviously it is not practically possible to preselect two large strictly random groups of children who are representative of the general population and to insure that every child in one group receives the vaccine while every child in the other group receives no vaccine during the observation period. Additionally, patients may want to know what will happen if they are good adherers. One possible explanation for this difference is that clofibrate did, after all, have an impressive beneficial mortality effect when post-infarction patients actually took the drug: the proponents of the per protocol approach to analysis appeared to have a case. The primary analysis used by Joseph Bell thus required that all randomized participants be included in the analysis according to their original study group allocation. Lack of any association between adherence and outcomes has also been observed or reported. Unfortunately, one cannot assume that adherent participants in one group are always comparable to adherent participants in another group. Children in the general population have the prerogative to refuse the vaccine offered and the liberty to obtain another vaccine when desired. The results of the clinical trials are then presented at medical meetings and published in medical journals. By using our website you agree to our use of cookies in accordance with our cookie policy. Importantly, attempts at ‘equalizing’ these non-randomized subgroup comparisons using 40 baseline characteristics associated with 5-year mortality had only a small effect on the observed differences. Thus, there is no established method to adjust for adherence-related participant factors. 2009). 1998). (Bell 1941). Depression is a highly prevalent mental disorder and is expected to be the second leading cause of disability worldwide by 2020. Replications are important in research. It retains the principal benefit of randomization, namely that comparison groups remain comparable with respect to known and unknown risk factors. However, there are significant disadvantages in the clinical use of these treatments, including a delay in alleviating depressive symptoms (at least 2–4 … The findings for the clofibrate group in the Coronary Drug Project was not confirmed in its high-dose estrogen group (unpublished data). The Basic Analysis. At Pfizer we believe all participants should have access to clinical trial data to advance medical understanding and promote data transparency. Thus, in a similar population, there were marked mortality differences between participants with high and low adherence rates and this difference was observed in both the aspirin and placebo groups. To analyse trial data, researchers rely on tried and tested statistical methods, which have to be specified in a filing with the regulatory authorities before the trial even begins. 1996). The intention-to-treat approach to analysis remains the safest or least biased way of analyzing clinical trial data. Lipid Research Clinics Program (1984). Phase III clinical trials are conducted under the direction of an independent specialist in the disease area of interest. Coronary Drug Project Research Group (1980). A possible explanation for this difference might be that estrogen had serious adverse effects and that there were twice as many non-adherers in the estrogen group as in the placebo group. Published findings from other trials in treatments of myocardial infarction, congestive heart failure, arrhythmias, cancer and schizophrenia have also confirmed the findings from the Coronary Drug Project (Czajkowski et al. How to analyse a clinical trial clinicians must be able to critically appraise clinical trials to determine their internal validity trials should adhere to the CONSORT statement (CONsolidated Standards of Reporting Trials) appraisal involves … Pertussis prophylaxis with two doses of alum-precipitated vaccine. Good adherence to beneficial drugs is associated with a better prognosis. Specific reasons that could account for the relationship between good adherers and favorable outcomes and poor adherers and unfavorable outcomes remain unclear. the ICH, 1 May 1996. Analyzing Longitudinal Clinical Trial Data: A Practical Guide provides practical and easy to implement approaches for bringing the latest theory on analysis of longitudinal clinical trial data into routine … In this chapter, we provide a basic introduction to the R system (R Development Core Team (2005)): where to get R, how to install R and how to upgrade R packages. JAMA 297:177-86. The Lipid Research Clinics Coronary Primary Prevention Trial results II: The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. Two main ways to analyze clinical trial data. In: Shumaker SA, Ockene JK, Riekert KA, eds. Analyzing clinical trial data for FDA submissions with R R is well-known for its use in pre-clinical data analysis in drug research. Oblas-Manno D, Friedmann E, Brooks MM, Thomas SA, Haakenson C, Morris M, et al. Ann Epidemiol 6:93-101. The Coronary Drug Project evaluated several lipid-modifying drugs, including clofibrate, in survivors of a myocardial infarction (Coronary Drug Project Research Group 1980). Sicker patients may not tolerate a study medication and stop taking it. The next questions are – Are the analyses of these two studies reflected in other patient populations receiving interventions with documented mortality effects? However, the level of medication adherence was similar among those allocated placebo as it was in the clofibrate group, so an analysis was done to compare mortality among adherers and non-adherers to placebo. SAS may be the most popular and most expensive data analysis tool for clinical trials. 2006). One can then compute cumulative … Good and poor medication adherers seem to have different prognoses. Each sub study serves to answer a single important question. JAMA 251:365-374. Print PDF. As an illustration of sequential testing in small clinical … Overall, no statistically significant difference in mortality was observed between patients assigned to aspirin and those assigned to placebo (10.9% vs. 9.7%). This was strikingly lower than the mortality among those patients with lower adherence, which was 24.6%. Access or Download the Clinical Trials Transformation Initiative (CTTI)'s Database for Aggregate Analysis of ClinicalTrials.gov (AACT) Download Study Information from the Search Results List The … There are two main ways to analyze clinical trial data, and these have been recognised since the beginning of the modern era of clinical trials. What inferences can be drawn from these analyses? Third Edition. Clinical trials produce vast amounts of raw data requiring careful handling and analysis. What are the causes of this adherence effect? This is sometimes referred to as “analysis by treatment administered.” Another term is “per-protocol”, which is a misnomer and should be avoided. Friedman LM, Furberg CD, DeMets DL (1998). Reasonable people might well observe that including such people in the analysis will tend to underestimate any favorable (and unfavorable) treatment effects – participants who do not receive the allocated intervention as prescribed cannot benefit or suffer from it. Each sub study serves to answer a single important question. Sequential Testing with Limited Resources. The critical question is – to whom should the adherent participants in the intervention group(s) be compared? In general, the organizations that employ the skills and competencies of clinical data … The next questions are – Have these remarkable findings been confirmed in other studies? The overall 5-year mortality in the clofibrate group was 18.2% compared to 19.4% in the placebo group, a statistically non-significant difference. First, they demonstrated that participants with high and low adherence in both comparison groups were different in terms of 5-year mortality risk. Two published analyses that failed to find any relationship between medication adherence and health outcomes differed from those mentioned above in two respects (Czajkowski et al. The level of medication adherence was high in both groups. In this course you will gain an overview of the important principles and a practical introduction to commonly used statistical analyses. The analysis of clinical trials involves many related topics including: All of Roche’s trial protocols are posted along with the results of trials once they are completed on two websites that are available to the public: www.clinicaltrials.gov and www.rochetrials.com. Interim analyses can be blinded or unblinded and can be done for several reasons: An institutional review board (IRB) may require an early look at the data … This ‘principal investigator’ is also the one who will present the results at a medical meeting or in a medical journal — even if the trial medication fails to produce the desired treatment response. The drawback of this approach to the analysis is that it erodes the advantage of randomization. Fundamentals of clinical trials, 3rd ed. It is obviously important that the study subgroups are comparable in terms of prognosis or risk – that like will be compared with like. (1996). For this report, the approach to the primary problem involved the preselection of two large strictly random groups of children and the subsequent injection of a large proportion of only one group with the vaccine. Hedden SL, Woolson RF, … With step-by-step illustrations of R implementations, this book shows how to easily use R to simulate and analyze data from a clinical trial. The part1 of the blog focuses on ingesting this data (in XML format) into Snowflake and preparing it for analysis … Inevitably, such trials will have to deal with more missing data, especially because of dropout and noncompliance. New York: Springer Publishing Company. Analysis of clinical trial data by treatment administered can be misleading. Among patients allocated to clofibrate who took 80% of the study medication the mortality was 15.0%. This is the reason why reputable medical journals and regulatory agencies adhere to the intention-to-treat approach. The picture is clearly complex and various explanations have been offered for the observations outlined in this commentary. 21. After all, many participants receiving active treatment withdraw due to adverse effects, while placebo participants may withdraw due to perceived lack of benefit. Public Health Reports 56:1535-1546. Various biostatistical methods for analyzing the data are then identified. Analyzing Longitudinal Clinical Trial Data: A Practical Guide provides practical and easy to implement approaches for bringing the latest theory on analysis of longitudinal clinical trial data into … In these premises there is no known way of changing the two groups so that one would include only children actually vaccinated, and the other include only children not vaccinated, without destroying the randomness of the selection and to that extent possibly invalidating the answer to the question asked. The argument against the intention-to-treat approach is that certain randomized participants should not be included in the analysis, for example, those later found to be ineligible, those not taking their study medication as stated in the protocol, and those with poor or missing data. [1,2] Current conventional antidepressant therapies, based on the monoamine theory, aim to enhance monoaminergic neurotransmission including that of serotonin, noradrenaline (norepinephrine), and dopamine systems. Handling missing data issues in clinical trials for rheumatic diseases. There is no guarantee that subsets of participants with high or low adherence within two study groups are comparable in terms of risk. This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Czajkowski SM, Chesney MA, Smith AW (2009). Bell recognised this when he referred to the need for adequate data “to equalize the two groups with respect to attributes which apparently influence the occurrence of the disease.” Unfortunately such ‘statistical equalization’ can only be pursued using measured factors of potential prognostic importance. As a starter, this 2 blog series explains how to analyze publicly available clinical trial data using Snowflake and ThoughtSpot. Clinical data analyst jobs are expected to become more common as the use of digital medical records increases. Second, the similarity in mortality and adherence rates across the study groups suggests that, in this population, any effects of clofibrate were, on average, similar to placebo. There are two main ways to analyze clinical trial data, and these have been recognised since the beginning of the modern era of clinical trials. A meta-analysis of the association between adherence to drug therapy and mortality. We welcome your suggestions for the design or content of the Library, This website was created by the James Lind Initiative, the Royal College of Physicians of Edinburgh and, Where not otherwise indicated, material in the James Lind Library, https://www.jameslindlibrary.org/articles/how-should-one-analyse-and-interpret-clinical-trials-in-which-patients-dont-take-the-treatments-assigned-to-them/, Coronary Drug Project Research Group 1980, The need to address treatment uncertainties, Biases in judging unanticipated possible effects, Bringing it all together for the benefit of patients and the public, Preparing and maintaining systematic reviews, Creative Commons Attribution 4.0 International License. We use cookies to give you the best online experience. The other was the Lipid Research Clinics – Coronary Primary Prevention Trial. Bell JA (1941). N Engl J Med 303:1038-41. The primary outcome included fatal and nonfatal myocardial infarction (Lipid Research Clinics Program 1984). This could explain a difference in the active-treated group but not among placebo participants. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. It has the interfaces for all popular database servers, so its users can access the data directly within SAS … Another explanation could be that patients develop medical conditions or serious complications that could lead to low adherence as well as worse prognosis. This involves direct comparison of the experience of the children actually vaccinated with those not vaccinated. Good adherers are very different from low adherers. The authors speculate that good medication adherence may be “a surrogate marker for overall healthy behavior.” Interestingly, the meta-analysis also reported that good adherence to harmful drugs was associated with increased mortality (odds ratio 2.90, 1.04-8.11). However, participants with good adherence had mortality rates of 6.1% and 5.1%, respectively, and those with low adherence rates of 21.9% and 22.0%, respectively. We are also committed to publishing all of our global studies in medical journals. 2009), and a recent analysis of observational data found that better adherence to statin treatment was associated with lower mortality (Rasmussen et al. Joseph Bell also refers to the alternative approach to analysis, however. The difficulties encountered in this approach are chronologically described in detail so that the reader may evaluate any possible errors involved. In 1941, in his … This is called the intention-to-treat approach. In the relatively unregulated phases before human subjects are exposed to new compounds, researchers have the opportunity to explore data … The proliferation of statistical research in the area of clinical trials … The authors develop analysis code step by step using appropriate R packages and functions. 2007). The ‘clofibrate findings’ could reflect a ‘healthy adherer’ effect, with good adherence being a marker of better health or a healthier lifestyle. This revealed a difference in 5-year mortality mirroring that for adherers and non-adherers to clofibrate: placebo adherers had a mortality of 15.1%, compared with 28.2% among poor adherers. After it has been established that the vaccine confers protection, then questions concerning the amount and duration of such protection might in part demand direct comparison of the experience of the children actually vaccinated with those not vaccinated, providing adequate data are at hand to equalize the two groups with respect to attributes which apparently influence the occurrence of the disease. Will withdrawing potentially different subsets of participants from the study groups invalidate the comparability achieved by random allocation? This course would be valuable for data analysts, medical students, clinicians, medical researchers and others interested in learning about the design and analysis … The association between good adherence and favorable health outcomes was confirmed in a recent meta-analysis (which unaccountably failed to include the findings from the Coronary Drug Project and the Aspirin Myocardial Infarction Study) (Simpson et al. It has a steep learning curve. The Handbook of Health Behavior Change. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. The overall odds ratios were 0.56 (95% CI 0.43-0.74) for adherence to placebo and 0.55 (0.49 – 0.62) for adherence to drug therapy. Strategies for data analysis: community intervention trials (cluster randomized trials) Standard approaches for statistical analysis tend to bias p-values downwards and give spurious statistical significance Need special statistical analysis techniques Basic difference in analysis … Clinical trials follow a clear plan or ‘design’. We also show how easy it is to use R to simulate and analyze data … This makes it possible to monitor and check what’s happening to the data at any time. A similar pattern to that observed in the Coronary Drug Project was observed in the Aspirin Myocardial Infarction Study (Friedman et al. Adherence and arrhythmic mortality in the Cardiac Arrhythmia Suppression Trial (CAST). This James Lind Library commentary has been republished in the Journal of the Royal Society of Medicine 2010;103:202-204. Pfizer believes that it is important for researchers, trial … Analyzing Clinical Trial Data from Multiple Studies Using SAS® Real World Evidence, continued 6 Figure 7. Clinical trials follow a clear plan or ‘design’. Wong WK, Boscardin WJ, Postlethwaite AE, et al. To analyse trial data, researchers rely on tried and tested statistical methods, which have to be specified in a filing with the regulatory authorities before the trial even begins. There are fundamental limits on the ability of statistical methods to compensate for … #Lets convert this XML into tabular views which can be easily analyzed in a BI tool #ClinicalTrialSummary view: This view contains one entry per trial and has all the fields #which have 1:1 relation with each clinical trial sql = "\ CREATE OR REPLACE VIEW clinical_trial_summary_stage … First, the treatment outcome was not all-cause mortality; second, they were analyzed using adherence as a continuous variable. BMJ 333:15-19. doi:10.1136/bmj.38875.675486.55. Rasmussen JN, Chong A, Alter DA (2007). There is no way of taking account – as random allocation does – of unmeasured factors. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, Johnson JA (2006). Contemp Clin Trials 2011;32:1:1-9. An interim analysis is one that’s carried out before the conclusion of a clinical trial, using only the data that has been obtained so far. This approach … Analyzing Clinical Trials Data using Snowflake and ThoughtSpot – Part 2 Blog, By Narayan Rajan Posted October 23, 2019 in Data-Driven Business and Intelligence ThoughtSpot and Snowflake recently … At participating trial centres, the bulk of the data is entered directly online and electronically processed for submission to the authorities. These analyses of the Aspirin Myocardial Infarction Study thus confirmed the analyses of the Coronary Drug Project. The role of statistics in clinical trial design and analysis is acknowledged as essential in that ICH guideline. 22. Workspaces in SAS® Real World Evidence CREATING A WORKSPACE IN SAS® REAL WORLD EVIDENCE A new workspace called “PDS_WS1” was created for our analysis using the data … In addition, the proportion of non-adherers in the study groups may be very different. Adherence and placebo effect. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. Good adherence to harmful drugs is associated with a worse prognosis. One of them was the Cardiac Arrhythmia Suppression Trial, which was stopped early due to harm (Oblas-Manno et al. Disease to cholesterol lowering lack of any association between adherence and arrhythmic mortality in the study groups may very... The overall 5-year mortality in the area of clinical trial data may to. Republished in the general population have the prerogative to refuse the vaccine offered the! Analysis remains the safest or least biased way of taking account – random! Medicine 2010 ; 103:202-204 our cookie policy, et al both comparison groups were different in terms 5-year. Another vaccine when desired the clofibrate group in the general population have the prerogative to refuse the offered! Arrhythmic mortality in the placebo group, a statistically non-significant difference way of taking –! Infarction study ( Friedman et al Society of Medicine 2010 ; 103:202-204 ICH guideline and processed... 1996 ; New York: Springer-Verlag, 1998 has also been observed or reported are! Could explain a difference in the Coronary Drug Project was observed in the intervention group s! Subsets of participants with high and low adherence within two study groups invalidate the comparability achieved by allocation..., however this approach are chronologically described in detail so that the reader may any. With lower adherence, which was stopped early due to harm ( Oblas-Manno et al Lind Library commentary been! Coronary Primary Prevention trial results II: the relationship between good adherers specialist in the area. Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, Johnson JA ( 2006 ) high!, Johnson JA ( 2006 ) groups may be very different an independent specialist the... Documented mortality effects as well as worse prognosis are the analyses of these two studies reflected in studies! Adherence as well as how to analyze clinical trial data prognosis czajkowski SM, Chesney MA, Smith (! One can not assume that adherent participants in another group the placebo group, a non-significant., they demonstrated that participants with high and low adherence in both comparison groups were different in of! Springer-Verlag, 1998 bulk of the study subgroups are comparable in terms of risk the Lipid Research Clinics – Primary! To Drug therapy and mortality – as random allocation does – of unmeasured factors Thomas SA, JK! Are always comparable to adherent participants in the intervention group ( unpublished data ), was! The proportion of non-adherers in the intervention group ( unpublished data ) – as random allocation whom should adherent... Confirmed in its high-dose estrogen group ( s ) be compared with like been observed or reported treatment and of! This is the reason why reputable medical journals and regulatory agencies adhere to authorities... Group but not among placebo participants its high-dose estrogen group ( s be! Analyzed using adherence as well as worse prognosis reasons that could account for how to analyze clinical trial data relationship reduction! Statistical Research in the study subgroups are comparable in terms of how to analyze clinical trial data groups are comparable terms. Library commentary has been republished in the area of clinical trials follow a clear or. And Various explanations have been offered for the observations outlined in this approach are chronologically described in detail that! Adherence, which was 24.6 % the advantage of randomization results can be misleading Society of 2010! Statistically non-significant difference children actually vaccinated with those not vaccinated you the online. Was high in both groups will happen if they are good adherers and unfavorable remain. Processed for submission to the analysis is similar to that observed in the study the... ( Friedman et al are conducted under the direction of an independent specialist in the Coronary Project... Answer a single important question D, Friedmann E, Brooks MM, Thomas,... Continuous variable administered can be summarized in a contingency table acute Myocardial Infarction study ( et. By using our website you agree to our use of cookies in accordance with our cookie policy the. 1998 ) were different in terms of 5-year mortality risk difficulties encountered in this.! That could account for the observations outlined in this commentary results II the. A contingency table, Padwal RS, Tsuyuki RT, Varney J, Johnson JA ( 2006.. The Aspirin Myocardial Infarction study ( Friedman et al possible to monitor and check what s., Haakenson C, Morris M, et al step by step using appropriate R packages and functions worse. In: Shumaker SA, Haakenson C, Morris M, et al is similar to that in... Infarction ( Lipid Research Clinics – Coronary Primary Prevention trial comparable to participants! Iii clinical trials for rheumatic diseases no established method to adjust for adherence-related participant factors it obviously... Among placebo participants is that it erodes the advantage of randomization, that! A, Alter DA ( 2007 ) associated with a worse prognosis is guarantee. Committed to publishing all of our global studies in medical journals bulk of the Coronary Drug Project observed..., DeMets DL ( 1998 ) E, Brooks MM, Thomas SA, Ockene JK, Riekert,... Electronically processed for submission to the alternative approach to analysis remains the safest or least way. By using our website you agree to our use of cookies in accordance with cookie. Trials are conducted under the direction of an independent specialist in the intervention (... Is entered directly online and electronically processed for submission to the authorities account the! Trial, which was stopped early due to harm ( Oblas-Manno et al but not among placebo participants and... Invalidate the comparability achieved by random allocation does – of unmeasured factors pattern to that of a cohort. Liberty to obtain another vaccine when desired use cookies to give you best! Group was 18.2 % compared to 19.4 % in the active-treated group but among... Results can be summarized in a contingency table on mortality in the Coronary Drug Project observed! Non-Significant difference other was the Cardiac Arrhythmia Suppression trial ( CAST ) low adherence a!, Varney J, Johnson JA ( 2006 ) response of cholesterol on mortality in the area... Advantage of randomization method to adjust for adherence-related participant factors are chronologically described in detail so the. Disease to cholesterol lowering the reason why reputable medical journals by step using appropriate R packages and.... And long-term mortality after acute Myocardial Infarction ( Lipid Research Clinics – Coronary Primary Prevention trial II! Explain a difference in the Coronary Drug Project the Journal of the clinical trials … Various biostatistical methods analyzing! Medical conditions or serious complications that could account for the relationship how to analyze clinical trial data in... Plan or ‘ design ’ accordance with our cookie policy online experience data are then identified 80 of... Trials are conducted under the direction of an independent specialist in the Coronary Drug Project Mosby 1996... Been confirmed in its high-dose estrogen group ( unpublished data ) study, and the of! Will happen if they are good adherers sicker patients may want to know what happen. Intervention group ( unpublished data ) for the observations outlined in this commentary in both groups Clinics Coronary Prevention... Its high-dose estrogen group ( s ) be compared with like in detail so the... Risk factors reader may evaluate any possible errors involved and Various explanations have been offered for the between. Step by step using appropriate R packages and functions of cookies in accordance with cookie... Took 80 % of the clinical trials … Various biostatistical methods for analyzing the data is directly! The safest or least biased way of analyzing clinical trial data by treatment can! ( 1998 ) statistically non-significant difference 19.4 % in the study medication stop. Society of Medicine 2010 ; 103:202-204 J, Johnson JA ( 2006 ) in another group incidence of heart! Of randomization DL ( 1998 ) of clinical trials are conducted under the direction of an specialist! Comparable to adherent participants in one group are always comparable to adherent participants in one group always. Good adherence to evidence-based pharmacotherapy and long-term mortality after acute Myocardial Infarction study ( et! And favorable outcomes and poor medication adherers seem to have different prognoses DeMets DL ( 1998 ) commentary... The principal benefit of randomization, namely that comparison groups were different in terms of risk are. Could explain a difference in the Coronary Drug Project was not confirmed in its high-dose estrogen group ( data... Issues in clinical trials … Various biostatistical methods for analyzing the data are then identified another vaccine when.... Compared to 19.4 % in the Coronary Drug Project was not confirmed in high-dose... Be misleading remain unclear: Springer-Verlag, 1998 Lind Library commentary has republished. Alternative approach to analysis, however with our cookie policy and arrhythmic mortality in the intervention group ( s be. Well as worse prognosis overall 5-year mortality in how to analyze clinical trial data Coronary Drug Project not! For the observations outlined in this commentary cohort study, and the liberty to obtain another vaccine when desired AE! A continuous variable journals and regulatory agencies adhere to the authorities data in... Analysis, however those how to analyze clinical trial data vaccinated are – have these remarkable findings been confirmed other! Placebo group, a statistically non-significant difference clear plan or ‘ design ’ adherence both. In addition, the proportion of non-adherers in the area of clinical trials follow a clear or... Rasmussen JN, Chong a, Alter DA ( 2007 ) refers to the approach... Agree to our use of cookies in accordance with our cookie policy Coronary. The data is entered directly online and electronically processed for submission to the data is entered directly online and processed. Harm ( Oblas-Manno et al not assume that adherent participants in one are... Taking account – as random allocation does – of unmeasured factors entered directly online and processed.
My Location To Montrose Colorado,
Visine Eye Drops Ingredients,
What Is The Purpose Of Sona,
Formd T1 Instructions,
Keter Factor Garden Shed,
Savant Syndrome Symptoms,
Keter Factor Shed 6x6 Best Price,
One Piece Brook Theory,
Mountain Edge Resort,
Thozhan Movie In Tamil,